CMS Proposal Would Limit Industry Practice That Raises Costs For Some Medicare Drug Plan Beneficiaries

A CMS proposal under consideration would limit a practice used by pharmacy benefit managers known as “lock-in pricing” that can increase costs for beneficiaries enrolled in the Medicare drug benefit and bring them into the so-called “doughnut hole” coverage gap more quickly, the Wall Street Journal reports. The doughnut hole begins when total annual drug spending by beneficiaries and their health insurers reaches $2,510.

More: continued here

Filed under: Medicare / Medicaid / Tricare on July 25th, 2008